BFEC
TSVT

Benjamin F. Edwards & Company’s 2seventy bio TSVT Stock Holding History

Benjamin F. Edwards & Company’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33
Closed -$1K – 1904
2022
Q1 		$1K Hold
33
– – ﹤0.01% 1737
2021
Q4 		$1K Buy
+33
New +$1.03K ﹤0.01% 1684

Other funds holding TSVT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Benjamin F. Edwards & Company's TSVT Position: Q2 2022 in Review

Benjamin F. Edwards & Company sold out of 2seventy bio (TSVT) in Q2 2022, closing a stake of 33 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in TSVT in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 132 funds tracked by Wall St. Rank hold TSVT as of Q2 2022.

  • Benjamin F. Edwards & Company reported no remaining 2seventy bio position as of Q2 2022 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 33 2seventy bio shares in Q2 2022, an estimated $1K.
  • Benjamin F. Edwards & Company first reported a position in 2seventy bio in Q4 2021 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's 2seventy bio position peaked at $1K in Q1 2022.
  • 132 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2022, filed 12 Aug 2022.